News Focus
News Focus
Followers 39
Posts 7307
Boards Moderated 3
Alias Born 05/06/2014

Re: tradinguru post# 99536

Wednesday, 05/25/2016 12:33:48 PM

Wednesday, May 25, 2016 12:33:48 PM

Post# of 105535
The 300 samples is an estimate based on actual numbers reported to the SEC for the 1st quarter 2016.The reasoning was explained and posted twice. CBAI states how much of the revenues are recurring, leaving the remainder for new accounts. Rational determination and straight forward. The one time fee for a new a account is clear $975. Since they have lost most of there tissue sales there are appox. 300 new customers for cord blood .

What is the basis for the accusation that there is under the table payments based on? Can't wait for the SEC report, probably won't live another 100 years.

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up